These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 20651158

  • 1. Activation of NFAT signaling in podocytes causes glomerulosclerosis.
    Wang Y, Jarad G, Tripathi P, Pan M, Cunningham J, Martin DR, Liapis H, Miner JH, Chen F.
    J Am Soc Nephrol; 2010 Oct; 21(10):1657-66. PubMed ID: 20651158
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.
    Nijenhuis T, Sloan AJ, Hoenderop JG, Flesche J, van Goor H, Kistler AD, Bakker M, Bindels RJ, de Boer RA, Möller CC, Hamming I, Navis G, Wetzels JF, Berden JH, Reiser J, Faul C, van der Vlag J.
    Am J Pathol; 2011 Oct; 179(4):1719-32. PubMed ID: 21839714
    [Abstract] [Full Text] [Related]

  • 3. TRPC6 mutations associated with focal segmental glomerulosclerosis cause constitutive activation of NFAT-dependent transcription.
    Schlöndorff J, Del Camino D, Carrasquillo R, Lacey V, Pollak MR.
    Am J Physiol Cell Physiol; 2009 Mar; 296(3):C558-69. PubMed ID: 19129465
    [Abstract] [Full Text] [Related]

  • 4. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
    Verheijden KAT, Sonneveld R, Bakker-van Bebber M, Wetzels JFM, van der Vlag J, Nijenhuis T.
    J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Gq signaling causes glomerular injury by activating TRPC6.
    Wang L, Jirka G, Rosenberg PB, Buckley AF, Gomez JA, Fields TA, Winn MP, Spurney RF.
    J Clin Invest; 2015 May; 125(5):1913-26. PubMed ID: 25844902
    [Abstract] [Full Text] [Related]

  • 9. Podocyte-specific overexpression of wild type or mutant trpc6 in mice is sufficient to cause glomerular disease.
    Krall P, Canales CP, Kairath P, Carmona-Mora P, Molina J, Carpio JD, Ruiz P, Mezzano SA, Li J, Wei C, Reiser J, Young JI, Walz K.
    PLoS One; 2010 Sep 20; 5(9):e12859. PubMed ID: 20877463
    [Abstract] [Full Text] [Related]

  • 10. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
    Sonneveld R, Ferrè S, Hoenderop JG, Dijkman HB, Berden JH, Bindels RJ, Wetzels JF, van der Vlag J, Nijenhuis T.
    Am J Pathol; 2013 Apr 20; 182(4):1196-204. PubMed ID: 23385000
    [Abstract] [Full Text] [Related]

  • 11. Participation of the AngII/TRPC6/NFAT axis in the pathogenesis of podocyte injury in rats with type 2 diabetes.
    Ma R, Xu Y, Zhou H, Zhang D, Yao D, Song L, Liu Y.
    Mol Med Rep; 2019 Mar 20; 19(3):2421-2430. PubMed ID: 30664212
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury.
    Zhang B, Shi W, Ma J, Sloan A, Faul C, Wei C, Reiser J, Yang Y, Liu S, Wang W.
    J Mol Med (Berl); 2012 Dec 20; 90(12):1407-20. PubMed ID: 23015147
    [Abstract] [Full Text] [Related]

  • 14. Gain-of-function mutations in transient receptor potential C6 (TRPC6) activate extracellular signal-regulated kinases 1/2 (ERK1/2).
    Chiluiza D, Krishna S, Schumacher VA, Schlöndorff J.
    J Biol Chem; 2013 Jun 21; 288(25):18407-20. PubMed ID: 23645677
    [Abstract] [Full Text] [Related]

  • 15. Inducible ATF3-NFAT axis aggravates podocyte injury.
    Zhang H, Liang S, Du Y, Li R, He C, Wang W, Liu S, Ye Z, Liang X, Shi W, Zhang B.
    J Mol Med (Berl); 2018 Jan 21; 96(1):53-64. PubMed ID: 29038896
    [Abstract] [Full Text] [Related]

  • 16. NADPH oxidase-derived ROS contributes to upregulation of TRPC6 expression in puromycin aminonucleoside-induced podocyte injury.
    Wang Z, Wei X, Zhang Y, Ma X, Li B, Zhang S, Du P, Zhang X, Yi F.
    Cell Physiol Biochem; 2009 Jan 21; 24(5-6):619-26. PubMed ID: 19910702
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Nuclear factor of activated T cells mediates RhoA-induced fibronectin upregulation in glomerular podocytes.
    Zhu L, Qi XY, Aoudjit L, Mouawad F, Baldwin C, Nattel S, Takano T.
    Am J Physiol Renal Physiol; 2013 Apr 01; 304(7):F849-62. PubMed ID: 23389455
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
    Husain S, Ginawi I, Bashir AI, Kfoury H, Al Johani TE, Hagar H, Raddaoui L, Al Ghonaim M, Alsuwaida A.
    Ultrastruct Pathol; 2018 Apr 01; 42(5):430-439. PubMed ID: 30285525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.